If you're having trouble viewing this,
Discover the Difference
Screening and Selectivity Profiling Service
Amphora Discovery’s PrecisionScreen™ and PrecisionSelect™ services deliver fast-turnaround, high data quality HTS and selectivity profiling for kinases, proteases, phosphatases, and HDACs.
All of Amphora’s PrecisionScreen™ and PrecisionSelect™ assays are run on the same platform and are biochemically and kinetically balanced, which allows direct comparability across targets and between screens.
- High throughput screening service utilizing Amphora’s highly efficient, validated and automated process.
- Capacity to rapidly screen small diversity sets or large libraries.
- Amphora offers multiple library options:
- Screening of all or a diversity sub-set of your library.
- Access Amphora’s unique 130,000 compound library.
- Access third party libraries from leading synthetic and natural products vendors.
- High-quality, rapid and efficient selectivity profiling services:
- Reliable and affordable, with flexible capacity to characterize 1 compound or whole libraries against multiple targets.
- Single concentration and IC50 analysis formats available.
- Create custom panels to meet your specific profiling needs by choosing any combination of the targets offered.
- Profiling can be scheduled to run weekly, monthly or quarterly to support rapid lead optimization; or can be scheduled for a single run as and when required.
Amphora Discovery Kinase List (March 2007)
Amphora Discovery Proteases Targets (March 2007)
Amphora Discovery Phosphatase Targets (March 2007)
Amphora Discovery HDAC's Targets (0707)
Download Amphora Discovery
Target List
For more information, please email sales@amphoracorp.com,
phone 919.287.6266 or visit our website at www.amphoracorp.com.
Contract Discovery Services for Assay Development, HTS, Selectivity Profiling & Lead Discovery.
Searching for a contract drug discovery research provider? Amphora Discovery provides high quality, cost effective contract drug discovery services proven to shorten traditional discovery timelines and deliver highly selective and potent lead candidates:
Custom assay development
Focused library screening, full HTS & high quality library access
Fast turnaround, high data quality selectivity profiling for Kinases, Proteases, Phosphatases and HDACs
Fully integrated drug discovery service, utilizing Amphora’s innovative and targeted lead generation and optimization solutions.
Rapidly access starting points and licensing opportunities by mining Amphora’s database of 97 completed HTSs and portfolio of confirmed drug-like series with detailed selectivity profiling data and initial SAR.
Selectivity
is a Process as well as a Result.
Be Selective.
Amphora Discovery
Amphora Discovery is a leading provider of integrated services for the pharmaceutical industry. We employ cutting-edge chemogenomic, systems biology and microfluidics technologies to deliver innovative and targeted lead generation and lead optimization solutions for our customers. Our mission is to enhance and improve the efficiency of our clients’ discovery efforts through a process that shortens traditional timelines.